A freeze–thaw cycle is one complete round trip of a solution from frozen state to liquid and back. Stability studies quote tolerance in numbers of such repetitions because the damage is cumulative and depends on how many transitions occur, not on total time spent frozen.
Why freeze–thaw damage matters in peptide research
Three mechanisms operate during the phase change. As ice forms, dissolved species are excluded from the crystal lattice and concentrate sharply in the shrinking liquid fraction, so local peptide and salt concentrations rise far above nominal. Buffer components can crystallise at different points — sodium phosphate buffers are known to shift pH by more than a unit on freezing — exposing the peptide to conditions it never sees at room temperature. And each ice-water interface offers a surface where partially unfolded chains associate irreversibly.
The visible result is haze, particulates or a drop in measured potency; the invisible one is a slow loss of the intact species that only a fresh HPLC check would reveal. The standard defence is to split a reconstituted stock into single-use aliquots before the first freeze, using sterile empty vials. Practical detail is in the storage guide and the aliquoting guide.